Vanda Pharmaceuticals
VNDA
#7540
Rank
S$0.51 B
Marketcap
S$8.74
Share price
11.39%
Change (1 day)
41.67%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Net assets

Net assets on the balance sheet as of September 2025 : S$0.60 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has S$0.60 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Vanda Pharmaceuticals - Net assets on balance sheet (from 2005 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$0.73 B1.72%
2023-12-31$S$0.71 B1.83%
2022-12-31$S$0.70 B3.54%
2021-12-31$S$0.68 B13.84%
2020-12-31$S$0.59 B8.23%
2019-12-31$S$0.55 B47.24%
2018-12-31$S$0.37 B114.12%
2017-12-31$S$0.17 B-7.55%
2016-12-31$S$0.19 B1.01%
2015-12-31$S$0.18 B-11.45%
2014-12-31$S$0.21 B280.1%
2013-12-31$S$55.9 M361.53%
2012-12-31$S$12.11 M-72.06%
2011-12-31$S$43.35 M-10.81%
2010-12-31$S$48.6 M50.32%
2009-12-31$S$32.33 M-50.87%
2008-12-31$S$65.81 M-45.38%
2007-12-31$S$0.12 B193.66%
2006-12-31$S$41.02 M-19.64%
2005-12-31$S$51.05 M96.29%
2004-12-31$S$26.01 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
S$57.94 B 9,503.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$30.88 B 5,018.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$102.65 B 16,912.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$24.08 B 3,891.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$120.54 B 19,877.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
S$3.61 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$67.21 B 11,038.87%๐Ÿ‡บ๐Ÿ‡ธ USA